Mark Carty
Impact in
- Molecular Biology top 10%
- Genomics and Chromatin Dynamics
- RNA Research and Splicing
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA and protein synthesis mechanisms
- Single-cell and spatial transcriptomics
- CRISPR and Genetic Engineering
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- MicroRNA in disease regulation 2
- Cancer Genomics and Diagnostics 1
-
- Genomics and Chromatin Dynamics 3
- RNA modifications and cancer 2
- Gene expression and cancer classification 2
- RNA and protein synthesis mechanisms 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Christina S. Leslie (3 shared papers)Raphael A. Pelossof (2 shared papers)Merve Şahin (1 shared paper)Lee Zamparo (1 shared paper)Alvaro J González (1 shared paper)Olivier Elemento (1 shared paper)Pieter Van Vlierberghe (1 shared paper)Andrew L. Wolfe (1 shared paper)
- Journals
- Nature (2 papers)Science Signaling (1 paper)Blood (1 paper)The International Journal of Life Cycle Assessment (1 paper)JCO Oncology Practice (1 paper)
- Partner nations
- United StatesBelgium
In The Last Decade
Mark Carty
7 papers receiving 1.6k citations
Mark Carty's Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Biology 1.2k
- Cancer Research 242
- Genetics 329
- Aging 15
- Immunology 90
Countries citing papers authored by Mark Carty
This map shows the geographic impact of Mark Carty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Carty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Carty more than expected).
Fields of papers citing papers by Mark Carty
This network shows the impact of papers produced by Mark Carty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Carty. The network helps show where Mark Carty may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Carty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Expanded encyclopaedias of DNA elements in the human and mouse genomes Hit paper breakdown → | 2020 | 1387 |
| 2 | 2020 | 138 | |
| 3 | 2017 | 52 | |
| 4 | 2014 | 35 | |
| 5 | 2010 | 19 | |
| 6 | 2014 | 2 | |
| 7 | 2022 | 1 | |
| 8 | 2025 | 0 |
About Mark Carty
Mark Carty is a scholar working on Cancer Research, Molecular Biology, Management, Monitoring, Policy and Law, Building and Construction and Environmental Engineering, having authored 8 papers that have together received 1.6k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (3 papers), RNA modifications and cancer (2 papers), Gene expression and cancer classification (2 papers), RNA and protein synthesis mechanisms (2 papers), Epigenetics and DNA Methylation (2 papers), MicroRNA in disease regulation (2 papers), Reproductive System and Pregnancy (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Molecular Biology (1.2k citations), Cancer Research (242 citations), Genetics (329 citations), Aging (15 citations) and Immunology (90 citations). Mark Carty has collaborated with scholars based in United States and Belgium. Frequent co-authors include Christina S. Leslie, Raphael A. Pelossof, Merve Şahin, Lee Zamparo, Alvaro J González, Olivier Elemento, Pieter Van Vlierberghe, Andrew L. Wolfe, Pieter Rondou and Viraj R. Sanghvi. Their work appears in journals such as Nature, Science Signaling, Blood, The International Journal of Life Cycle Assessment and JCO Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.